Advanced Search
Contact | Corporate | Help

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer

Sponsors:
  • Sarah Cannon Research Institute
  • Bristol-Myers Squibb
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Ixabepilone
  • Drug: Trastuzumab
  • Drug: Carboplatin
Enrollment:
60

Additional information about NCT00821886.


SourceSolution © 2008-2012